• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精中复杂卵巢过度刺激综合征是否存在预测标准?

Are there predictive criteria of complicated ovarian hyperstimulation in IVF?

作者信息

Delvigne A, Vandromme J, Barlow P, Lejeune B, Leroy F

机构信息

IVF Clinic, Saint Pierre Hospital, Free University of Brussels, Belgium.

出版信息

Hum Reprod. 1991 Aug;6(7):959-62. doi: 10.1093/oxfordjournals.humrep.a137469.

DOI:10.1093/oxfordjournals.humrep.a137469
PMID:1761666
Abstract

Among 599 trials of in-vitro fertilization (IVF) treatment, complicated ovarian hyperstimulation (OHSS) was diagnosed in 14 cases (2.5%) on the basis of heavy abdominal discomfort and echographic findings (ascites, ovarian enlargement with cysts). Among eight hospitalized patients, four presented with a haemoconcentration and/or electrolytic disturbances. OHSS cases were compared with two control groups for a series of criteria: age, aetiology of infertility, total dose of human menopausal gonadotrophin (HMG), day of oocyte collection, oestradiol (E2) peak level, rate of E2 increase, number of oocytes, number of embryos transferred and embryonic vitality scores. Comparison with a random group of normal IVF trials showed a significant difference for the following parameters: E2 peak level and rate of increase, E2/dose of HMG, E2/day of egg collection and number of oocytes. When OHSS cases were compared to another control group consisting only of high E2 responders (peak E2 greater than 2700 pg/ml), no significant difference was found for any of the above-mentioned criteria. In view of this lack of predictive power of individual criteria, stepwise discriminant analysis was applied, showing that this method might provide a predictive mathematical function for evaluating the risk of OHSS before human chorionic gonadotrophin (HCG) administration. Such a formula, however, should be validated by a multicentric study in which a greater number of OHSS cases would be tested.

摘要

在599例体外受精(IVF)治疗试验中,根据严重的腹部不适和超声检查结果(腹水、卵巢囊肿伴增大),确诊14例(2.5%)为复杂卵巢过度刺激综合征(OHSS)。在8例住院患者中,4例出现血液浓缩和/或电解质紊乱。将OHSS病例与两个对照组在一系列标准上进行比较:年龄、不孕病因、人绝经期促性腺激素(HMG)总剂量、取卵日、雌二醇(E2)峰值水平、E2升高率、卵母细胞数量、移植胚胎数量和胚胎活力评分。与一组随机的正常IVF试验组比较,以下参数有显著差异:E2峰值水平和升高率、E2/HMG剂量、E2/取卵日及卵母细胞数量。当将OHSS病例与另一个仅由高E2反应者(E2峰值大于2700 pg/ml)组成的对照组比较时,上述任何标准均未发现显著差异。鉴于个体标准缺乏预测能力,应用逐步判别分析,结果显示该方法可能提供一种预测数学函数,用于在注射人绒毛膜促性腺激素(HCG)前评估OHSS风险。然而,这样一个公式应由多中心研究进行验证,在该研究中要对更多的OHSS病例进行测试。

相似文献

1
Are there predictive criteria of complicated ovarian hyperstimulation in IVF?体外受精中复杂卵巢过度刺激综合征是否存在预测标准?
Hum Reprod. 1991 Aug;6(7):959-62. doi: 10.1093/oxfordjournals.humrep.a137469.
2
The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features.
Hum Reprod. 1993 Sep;8(9):1353-60. doi: 10.1093/oxfordjournals.humrep.a138260.
3
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
4
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.接受促性腺激素释放激素拮抗剂体外受精周期的女性中卵巢过度刺激综合征的发生率及预测
Fertil Steril. 2006 Jan;85(1):112-20. doi: 10.1016/j.fertnstert.2005.07.1292.
5
In-vitro fertilization and the ovarian hyperstimulation syndrome.体外受精与卵巢过度刺激综合征
Hum Reprod. 1992 May;7(5):597-600. doi: 10.1093/oxfordjournals.humrep.a137702.
6
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.在促性腺激素释放激素拮抗剂方案中使用注射用重组人促卵泡激素α或重组促卵泡素β治疗的患者中卵巢过度刺激综合征的预测
PLoS One. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615. eCollection 2016.
7
The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction.体外受精中的卵巢过度刺激综合征:一项比利时多中心研究。II. 风险预测的多重判别分析
Hum Reprod. 1993 Sep;8(9):1361-6. doi: 10.1093/oxfordjournals.humrep.a138261.
8
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.一种简化的体外受精促排卵方案通用方法:采用定制的最终卵泡成熟模式和时间的超短激动剂/拮抗剂联合方案。
J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3.
9
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).辅助生殖(体外受精和卵胞浆内单精子注射)中刺激周期的监测。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD005289. doi: 10.1002/14651858.CD005289.pub2.
10
[The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].[血管内皮生长因子和雌二醇在卵巢过度刺激综合征不孕患者中的预测作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jul;34(3):565-7.

引用本文的文献

1
What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.体外受精中重度卵巢过度刺激综合征的最佳预测指标是什么?一项队列研究。
J Assist Reprod Genet. 2017 Oct;34(10):1341-1351. doi: 10.1007/s10815-017-0990-7. Epub 2017 Jul 14.
2
Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.在辅助生殖治疗周期中,通过早期抽吸多囊卵巢的高反应性患者的小卵泡来预防卵巢过度刺激综合征。
MedGenMed. 2005 Aug 16;7(3):60.
3
Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).
利用刺激血清雌二醇测量预测体外受精(IVF)中卵巢刺激的高反应性。
J Assist Reprod Genet. 2004 Mar;21(3):65-72. doi: 10.1023/b:jarg.0000027016.65749.ad.
4
Acute arterial thrombosis after gamete intrafallopian transfer: a case report.配子输卵管内移植术后急性动脉血栓形成:一例报告
J Assist Reprod Genet. 1995 May;12(5):335-7. doi: 10.1007/BF02213715.